Roivant Sciences (ROIV) Total Liabilities (2020 - 2026)

Roivant Sciences has reported Total Liabilities for 7 years, with the latest figure at $416.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 66.68% year-over-year to $416.3 million; the trailing twelve-month figure through Mar 2026 stood at $416.3 million (up 66.68% YoY), and the FY2026 full-year result was $416.3 million, up 66.68% from the prior year.
• Total Liabilities for Q1 2026 stood at $416.3 million, up from $251.1 million in the prior quarter.
• The five-year high for Total Liabilities was $822.5 million in Q2 2022, with the low at $216.7 million in Q2 2025.
• Historically, Total Liabilities has averaged $560.3 million across 5 years, with a median of $626.0 million in 2024.
• Annual changes were most pronounced in 2022 — Total Liabilities surged 73.21% — and 2025, when it plunged 67.73%.
• Roivant Sciences' Total Liabilities stood at $775.8 million in 2022, then decreased by 6.15% to $728.1 million in 2023, then sank by 64.79% to $256.4 million in 2024, then declined by 2.04% to $251.1 million in 2025, then jumped by 65.75% to $416.3 million in 2026.
• The last three Total Liabilities figures came in at $416.3 million (Q1 2026), $251.1 million (Q4 2025), and $257.1 million (Q3 2025), per Business Quant data.